Literature DB >> 425926

Propranolol in human plasma and breast milk.

J H Bauer, B Pape, J Zajicek, T Groshong.   

Abstract

To assess the problem of continuing propranolol therapy in a breast-feeding mother, studies were performed to determine simultaneously plasma and breast milk concentrations of propranolol after single dose (40 mg) and continuous dose (40 mg 4 times daily) treatment with this drug. Breast milk and plasma concentrations of propranolol peaked between 2 and 3 hours after dosing. Propranolol concentrations in breast milk were less than 40 and 64 percent, respectively, of peak plasma propranolol concentrations after single dose and continuous dose administration. It was estimated that the maximal cumulative propranolol load to this breast-feeding infant, consuming 500 ml of whole milk, when the mother received 40 mg of propranolol 4 times daily would be 21 microgram/24 hours. This dose is considerably less than the usual therapeutic dose of propranolol for infants.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 425926     DOI: 10.1016/0002-9149(79)90090-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  To nurse when receiving acebutolol: is it dangerous for the neonate?

Authors:  M J Boutroy; G Bianchetti; C Dubruc; P Vert; P L Morselli
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Prediction of drug concentrations in human skim milk from plasma protein binding and acid-base characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

4.  Nadolol in human serum and breast milk.

Authors:  R G Devlin; K L Duchin; P M Fleiss
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

Review 5.  Hypertension in pregnancy. Pathophysiology and management.

Authors:  W F Lubbe
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

6.  Transfer of mepindolol to newborns by breast-feeding mothers after single and repeated daily doses.

Authors:  W Krause; I Stoppelli; S Milia; E Rainer
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 7.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

8.  Mexiletine in human blood and breast milk.

Authors:  A M Lewis; L Patel; A Johnston; P Turner
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

9.  Disopyramide and its N-monodesalkyl metabolite in breast milk.

Authors:  D B Barnett; S A Hudson; A McBurney
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 10.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.